Background
Acne conglobata (AC) is an uncommon and unusually severe form of acne characterized by burrowing and interconnecting abscesses and irregular scars (both keloidal and atrophic), often producing pronounced disfigurement. The comedones often occur in a group of 2 or 3, and cysts contain foul-smelling seropurulent material that returns after drainage. The nodules are usually found on the chest, the shoulders, the back, the buttocks, the upper arms, the thighs, and the face.[1] Acne conglobata may develop as a result of a sudden deterioration of existing active papular or pustular acne, or it may occur as the recrudescence of acne that has been quiescent for many years.
Nodules on the back. Courtesy of Emanuel G. Kuflik.
Nodules on the face. Courtesy of Emanuel G. Kuflik.
Nodules and pustules on the back. Courtesy of Emanuel G. Kuflik.
A close-up view of nodules and pustules on the back. Courtesy of Emanuel G. Kuflik. Pyoderma gangrenosum, acne conglobata, and aseptic arthritis are clinically distinct inflammatory disorders. Although this triad of symptoms rarely occurs in an individual patient, it was reported in a 3-generation kindred with autosomal dominant transmission of the 3 disorders; this condition is called familial pyoderma gangrenosum, acne conglobata, and aseptic arthritis (PAPA) syndrome.
Other acne-related eMedicine articles include Acne Fulminans, Acne Keloidalis Nuchae, Acne Vulgaris, and Acneiform Eruptions.
Pathophysiology
The primary causes of acne conglobata remain unknown. Chromosomal defects in the XXY karyotype may be responsible for severe forms of acne conglobata. In contrast, the XXY karyotype of Klinefelter syndrome is believed to exclude severe acne; however, 1 patient with the unusual combination of Klinefelter syndrome and acne conglobata has been reported.[2]
The association of this disease with specific human leukocyte antigen (HLA) phenotypes has not been proven. The HLA-A and HLA-B phenotypes were evaluated in 65 patients with acne conglobata, in whom antigen frequencies were found to be normal. Other patients with acne conglobata and hidradenitis suppurativa were studied; 4 of 6 patients had HLA-B7 cross-reacting antigens (ie, HLA-B7, HLA-Bw22, HLA-B27, HLA-Bw40, HLA-Bw42), and all had HLA-DRw4.[3]
PAPA syndrome has been mapped to a locus on the long arm of chromosome 15 (maximum 2-point logarithm of odds score 5.83; recombination fraction [straight theta] 0 at locus D15S206).[4] Assuming complete penetrance, haplotype analysis of recombination events defined an interval of 10 centimorgans between loci D15S1023 and D15S979. This finding suggests that these clinically distinct disorders may share a genetic etiology.
Epidemiology
Frequency
International
Acne conglobata is an uncommon disease.
Mortality/Morbidity
Acne conglobata can produce pronounced disfigurement. Severe scarring produces psychological impairment; individuals with acne conglobata are often ostracized, or they may feel excluded. Acne conglobata has also been responsible for anxiety and depression in many patients.
Sex
The disease affects males more frequently than females.
Age
The onset of acne conglobata usually occurs in young adults aged 18-30 years, but infants may develop this condition as well.
Patterson WM, Stibich AS, Dobke M, Schwartz RA. Mutilating facial acne conglobata. Cutis. Aug 2000;66(2):139-40. [Medline].
Wollenberg A, Wolff H, Jansen T, Schmid MH, Rocken M, Plewig G. Acne conglobata and Klinefelter's syndrome. Br J Dermatol. Mar 1997;136(3):421-3. [Medline].
Schackert K, Scholz S, Steinbauer-Rosenthal I, Albert ED, Wank R, Plewig G. Letter: HL-A antigens in acne conglobata: a negative study. Arch Dermatol. Sep 1974;110(3):468. [Medline].
Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet. Apr 2000;66(4):1443-8. [Medline].
Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges. Feb 2007;5(2):110-7. [Medline].
Leybishkis B, Fasseas P, Ryan KF, Roy R. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy. Am J Med Sci. Mar 2001;321(3):195-7. [Medline].
Velez A, Alcala J, Fernandez-Roldan JC. Pyoderma gangrenosum associated with acne conglobata. Clin Exp Dermatol. Nov 1995;20(6):496-8. [Medline].
Ehrenfeld M, Samra Y, Kaplinsky N. Acne conglobata and arthritis: report of a case and review of the literature. Clin Rheumatol. Sep 1986;5(3):407-9. [Medline].
Vasey FB, Fenske NA, Clement GB, Bridgeford PH, Germain BF, Espinoza LR. Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa. Clin Exp Rheumatol. Oct-Dec 1984;2(4):309-11. [Medline].
Ziff M, Maliakkal J. Acne conglobata and arthritis. Ann Intern Med. Mar 1983;98(3):417. [Medline].
Roldán JC, Terheyden H, Dunsche A, Kampen WU, Schroeder JO. Acne with chronic recurrent multifocal osteomyelitis involving the mandible as part of the SAPHO syndrome: case report. Br J Oral Maxillofac Surg. Apr 2001;39(2):141-4. [Medline].
Birnkrant MJ, Papadopoulos AJ, Schwartz RA, Lambert WC. Pyoderma gangrenosum, acne conglobata, and IgA gammopathy. Int J Dermatol. Mar 2003;42(3):213-6. [Medline].
Perez-Villa F, Campistol JM, Ferrando J, Botey A. Renal amyloidosis secondary to acne conglobata. Int J Dermatol. Mar 1989;28(2):132-3. [Medline].
Shimomura Y, Nomoto S, Yamada S, Ito A, Ito K, Ito M. Chronic glomerulonephritis remarkably improved after surgery for acne conglobata of the buttocks. Br J Dermatol. Aug 2001;145(2):363-4. [Medline].
el-Shahawy MA, Gadallah MF, Massry SG. Acne: a potential side effect of cyclosporine A therapy. Nephron. 1996;72(4):679-82. [Medline].
Sterling JB, Hanke CW. Dioxin toxicity and chloracne in the Ukraine. J Drugs Dermatol. Mar-Apr 2005;4(2):148-50. [Medline].
Ena P, Zanetti S, Sechi LA. Mycobacterium chelonae I infection mimicking acne conglobata in an immunocompetent host. Clin Exp Dermatol. Jul 2004;29(4):423-5. [Medline].
Tan BB, Lear JT, Smith AG. Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin Exp Dermatol. Jan 1997;22(1):26-7. [Medline].
Shirakawa M, Uramoto K, Harada FA. Treatment of acne conglobata with infliximab. J Am Acad Dermatol. Aug 2006;55(2):344-6. [Medline].
Bolz S, Jappe U, Hartschuh W. Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges. Jan 2008;6(1):44-7. [Medline].
Hasegawa T, Matsukura T, Suga Y, et al. Case of acne conglobata successfully treated by CO(2) laser combined with topical tretinoin therapy. J Dermatol. Aug 2007;34(8):583-5. [Medline].
Myers JN, Mason AR, Gillespie LK, Salkey KS. Treatment of acne conglobata with modern external beam radiation. J Am Acad Dermatol. Aug 6 2009;[Medline].
Wolber C, David-Jelinek K, Udvardi A, Artacker G, Volc-Platzer B, Kurz H. [Successful therapy of sacroiliitis in SAPHO syndrome by etanercept.]. Wien Med Wochenschr. Jan 25 2011;[Medline].
Leyden JJ, Mills OH, Kligman AM. Cryoprobe treatment of acne conglobata. Br J Dermatol. Mar 1974;90(3):335-41. [Medline].
Weinrauch L, Peled I, Hacham-Zadeh S, Wexler MR. Surgical treatment of severe acne conglobata. J Dermatol Surg Oncol. Jun 1981;7(6):492-4. [Medline].
Jeong S, Lee CW. Acne conglobata: treatment with isotretinoin, colchicine, and cyclosporin as compared with surgical intervention. Clin Exp Dermatol. Nov 1996;21(6):462-3. [Medline].
Hasegawa T, Matsukura T, Hirasawa Y, et al. Acne conglobata successfully treated by fractional laser after CO laser abrasion of cysts combined with topical tretinoin. J Dermatol. Feb 2009;36(2):118-9. [Medline].
Harth W, Hillert A, Hermes B, Seikowski K, Niemeier V, Freudenmann RW. [Suicidal behavior in dermatology]. Hautarzt. Apr 2008;59(4):289-96. [Medline].
Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Rook/Wilkinson/Ebling Textbook of Dermatology. Oxford, England: Blackwell Science; 1998:1967, 1979.
Cunliffe WJ. Acne. 3rd ed. London, England: Martin Dunitz Publishers; 1993.
Plewig G, Kligman AM. Acne and Rosacea. Berlin: Springer-Verlag; 1993:351-5.

